Figure 3
From: PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
Coexpression of PSMA and endothelial markers. (A–C) Follicular thyroid carcinoma with negative expression of PSMA (proportion score <5%) versus strongly positive CD105 and CD34. (D–F) Papillary thyroid carcinoma with concordant expression of PSMA, CD105, and CD34. Immunohistochemistry with anti-PSMA (A,D), anti-CD105 (B,E), and anti-CD34 (C,F). Serial sections, 100×.
